Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Neuromuscular Disorders : NMD|September 11, 2002
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy?Giuliana Ferrari, Fulvio MavilioBlood Cells, Molecules & Diseases|January 17, 2018
Gene therapy and gene editing strategies for hemoglobinopathiesMaria Rosa Lidonnici, Giuliana FerrariHematology/Oncology Clinics of North America|September 13, 2017
Gene Therapy Approaches to HemoglobinopathiesGiuliana Ferrari, Marina Cavazzana, Fulvio MavilioHuman Gene Therapy|September 7, 2023
Gene Therapy for HemoglobinopathiesMaria Rosa Lidonnici, Samantha Scaramuzza, Giuliana FerrariNature Reviews. Genetics|December 11, 2020
Gene therapy using haematopoietic stem and progenitor cellsGiuliana Ferrari, Adrian J Thrasher, Alessandro AiutiCell Reports. Medicine|November 18, 2025
Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow nicheAnnamaria Aprile, Maria Rosa Lidonnici, Giuliana FerrariPharmaceuticals (Basel, Switzerland)|May 28, 2022
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell DiseaseAnnamaria Aprile, Silvia Sighinolfi, Laura Raggi, et al.Stem Cells (Dayton, Ohio)|March 25, 2010
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathwayAlexandros Xynos, Paola Corbella, Nathalie Belmonte, et al.The Journal of Biological Chemistry|January 1, 2004
Deletion of a negatively acting sequence in a chimeric GATA-1 enhancer-long terminal repeat greatly increases retrovirally mediated erythroid expressionAnna Testa, Francesco Lotti, Linda Cairns, et al.Journal of Virology|March 22, 2002
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacementFrancesco Lotti, Emilio Menguzzato, Claudia Rossi, et al.Pageof 6